Summary
CNS Pharmaceuticals , Inc.
Founded in 2017
Description
CNS Pharmaceuticals is a biotechnology company specializing in the development of novel treatments for brain tumors. CNS Pharmaceuticals is developing novel treatments for primary and metastatic cancers of the brain and central nervous system. Its lead...
Strengths
- Revenue generated per employee is greater than industry average
Weaknesses
- CNS Pharmaceuticals , Inc. has a very small market share in their industry
Annual Revenue
CNS Pharmaceuticals , Inc.'s annual revenue
$1688000
Based on Kona Equity data
-
Revenue per employee
$562666
-
Annual revenue growth since founding
$241142
-
Revenue growth rate from first known quarter to current
-79.2%
Employee Count
3 employees
-
Employee growth rate from first known quarter to current
-79.2%
Executives
John Climaco
Chief Executive Officer
j**@cnspharma.comMichael Gaskell
Program Management Head
m**@cnspharma.comZena Muzyczenko
Global Director, Clinical Operations
z**@cnspharma.comChristopher Downs
Chief Financial Officer
c**@cnspharma.comPhone Pharmaceuticals
Chief Executive Officer
p**@cnspharma.comG Score - 1
The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.
- G2 Income per employee more than industry average.
Location
Unlock unlimited leads
Similar Companies
NeurOp
neuropinc.com- Founded in 2001
- Location: Atlanta, GA
- Annual Revenue: $977.0K
- Employees: 5
- NeurOp, Inc. is a clinical stage biotechnology company developing medicines for pain, stroke, subarachnoid hemorrhage, and treatment-resistant depression. Our compounds target various subunits of N methyl D aspartate (NMDA) receptors in the central ner...
Moleculin Biotech
moleculin.com- Founded in 2006
- Location: Houston, TX
- Annual Revenue: $4.4M
- Employees: 13
- Moleculin Biotech is a clinical stage pharmaceutical company focused on the treatment of highly resistant cancers. These resistant cancers range from deadly brain tumors, to pancreatic cancer, acute myeloid leukemia, among others.
AGY Therapeutics Inc
agyinc.com- Founded in 1998
- Location: South San Francisco, CA
- Annual Revenue: $10.9M
- Employees: 42
Get
g-e-t.co.kr- Annual Revenue: $4.0M
- Employees: 20
Praetego Inc
praetego.com- Location: Durham, NC
- Annual Revenue: $1.2M
- Employees: 5
- Praetego is a pharmaceutical company that develops new drugs to preserve health and protect patients from the complications of glucose dysregulation. They are committed to protecting patients from neurodegenerative diseases associated with aging, start...
Patrys
patrys.com- Founded in 2007
- Location: Melbourne, Victoria
- Annual Revenue: $21.0K
- Employees: 9
- Patrys Limited is a publicly listed company focused on developing novel antibody technologies for hard to treat cancers. They seek out cancer cells, naturally get inside cells and the cell nucleus, cross the blood brain barrier, and inhibit DNA damage ...
Key Information
- Name: CNS Pharmaceuticals , Inc.
- Category: Pharmaceuticals
- SIC: 87; 873
- NAICS: 5417; 541
See similar companies
-
By City Houston Pharmaceuticals in Houston Small Pharmaceuticals in Houston Mid-size Pharmaceuticals in Houston
-
By State TX Small companies in TX Pharmaceuticals in TX Small Pharmaceuticals in TX Mid-size Pharmaceuticals in TX
-
By Category Pharmaceuticals Small Pharmaceuticals Mid-size Pharmaceuticals G Score of 1
-
Firmographic data G Score of 1 Founded in 2017 SIC: 87 SIC: 873 NAICS: 5417 NAICS: 541 #Education General #Organizations General #Education #Organizations
Frequently Asked Questions
CNS Pharmaceuticals , Inc.'s headquarters are located at 2100 WEST LOOP SOUTH Ste. 900 Houston, TX 77027.
CNS Pharmaceuticals , Inc.'s official website is cnspharma.com
CNS Pharmaceuticals , Inc.'s annual revenue is $1.7 M.
CNS Pharmaceuticals , Inc.'s SIC: 87; 873
CNS Pharmaceuticals , Inc.'s NAICS: 5417; 541.
CNS Pharmaceuticals , Inc. has 3 employees
CNS Pharmaceuticals , Inc. is in the industry of Pharmaceuticals.
